These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5611331)

  • 21. [Efficacy of epimedium compound pills in the treatment of the aged patients with kidney deficiency syndrome of ischemic cardio-cerebral vascular diseases].
    Tan X; Weng W
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):450-2. PubMed ID: 10682558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of coronary disease in the Glasgow Homeopathic Hospital.
    Stewart TF
    J Am Inst Homeopath; 1966; 59(1):6-19. PubMed ID: 5951949
    [No Abstract]   [Full Text] [Related]  

  • 23. [Niamid in treatment of coronary disease].
    Chojnowski JR; Chojnowska-Jezierska J; Adamska-Marcinkowska H
    Wiad Lek; 1967 Feb; 20(3):235-8. PubMed ID: 6040308
    [No Abstract]   [Full Text] [Related]  

  • 24. [Coronary disease and antihypertensive treatment with beta blockers in older patients].
    Wikstrand J
    Cardiologia; 1984; 29(1-2):129-44. PubMed ID: 6152540
    [No Abstract]   [Full Text] [Related]  

  • 25. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia.
    Ozerova IN; Jeevan DM; Serdyuk AP; Paramonova IV; Akhmedzhanov NM; Metel'skaya VA; Perova NV
    Bull Exp Biol Med; 2000 Oct; 130(10):983-5. PubMed ID: 11177300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of digitalis preparations on the coronary vessels of patients with coronary insufficiency].
    Slutskiĭ ME; Vysokiĭ FF; Khvoĭnitskaia IL
    Ter Arkh; 1966 Dec; 38(12):42-5. PubMed ID: 6003267
    [No Abstract]   [Full Text] [Related]  

  • 27. Should we prescribe antioxidants to patients with coronary heart disease?
    Rapola JM
    Eur Heart J; 1998 Apr; 19(4):530-2. PubMed ID: 9597395
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of gamma-ketophenylbutazone (Ketazon SPOFA) on the level of serum cholesterol].
    Sitar J
    Vnitr Lek; 1968 Mar; 14(3):228-34. PubMed ID: 5638959
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency].
    Cinelli P; Grazzini M
    Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of thrombophilic syndromes. I. Coagulation changes in coronary arteriosclerosis, cerebral arteriosclerosis and peripheral artery arteriosclerosis].
    Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G
    Riv Crit Clin Med; 1968; 68(3):211-37. PubMed ID: 5737876
    [No Abstract]   [Full Text] [Related]  

  • 31. [Apropos of the use of "Segontin" in coronary patients].
    Arnoux E; Boutin C; Ohresser P; Olmer M; Luccioni L; Bory M
    Arch Med Gen Trop; 1965; 42(4):203-16. PubMed ID: 5846359
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experience with the prolonged use of beta-adrenergic blocking agents in the ambulatory treatment of patients with ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1980; 52(8):99-103. PubMed ID: 6114576
    [No Abstract]   [Full Text] [Related]  

  • 33. [Data on the hospital treatment of heart disease patients with proscillaridin A].
    Saccabusi E
    Recenti Prog Med; 1966 Jul; 41(1):XLIII-LIV. PubMed ID: 6014476
    [No Abstract]   [Full Text] [Related]  

  • 34. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 35. Dipyridamole in long-term treatment of coronary insufficiency.
    Gaddy CG
    Va Med Mon (1918); 1966 Jun; 93(6):336-9. PubMed ID: 5935173
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of Difril in patients with chronic coronary insufficiency].
    Gol'dberg VA
    Klin Med (Mosk); 1968 Jun; 46(6):100-3. PubMed ID: 5710560
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vitamin E treatment of patients with coronary disease (Cambridge Heart Antioxidant Study--CHAOS)].
    Mörike EM
    Dtsch Med Wochenschr; 1996 May; 121(21):A9. PubMed ID: 8646973
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ustimon (ST 7090) in the treatment of coronary disease].
    Chrzanowski W; Pracka H
    Wiad Lek; 1967 Jun; 20(12):1159-61. PubMed ID: 6056177
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fendiline (Sensit) in the treatment of coronary disease].
    Bała T; Gajewska B; Adamska-Dyniewska H
    Wiad Lek; 1983 Apr; 36(7):525-30. PubMed ID: 6349131
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of digitalis preparations on the coronary veins of patients with coronary insufficiency].
    Slutskiĭ ME; Vysokiĭ FF; Khvoĭnitskaia IL
    Ter Arkh; 1966 Dec; 39(12):42-5. PubMed ID: 6012204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.